Wednesday, February 17 8:45–9:45am
Screen. Assess. Act. A Primary Care Approach to Alcohol Use Disorder
Wednesday, February 17 8:45–9:45am
Screen. Assess. Act. A Primary Care Approach to Alcohol Use Disorder
Wednesday, February 17 8–8:45am
Updates in Cardiology: New Hypertension, Lipid, and CKM Guidelines
Tuesday, February 16 7:30–8:15am
But We’ve Always Done It That Way: Top 10 Recent Publications That Should Change Your Practice
Tuesday, February 16 1:45–2:45pm
What Are You Afraid Of? Prescribing Hormone Therapy with Confidence!
Earn CME/CE credits in the Nation's Capital.
Register NowFinancial Disclosures
- James Besante, MD
- No relevant financial relationships disclosed.
- Amy Clouse, MD, FAAFP
- Information to come
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Information to come
- Lawrence Herman, DMSc, MPA, PA-C, DFAAPA
- Consultant: Novo Nordisk; Speaker: Novo Nordisk
- Peter Lin, MD, CCFP
- Speaker: Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eisai, Eli Lilly, GSK, HLS Therapeutics, Medexus, Medtronic, Merck, Moderna, Novo Nordisk, Pfizer, Reckitt, Sanofi
- Rachel Rubin, MD
- No relevant financial relationships disclosed.
- Gerald W. Smetana, MD
- No relevant financial relationships disclosed
- Tina K. Thethi, MD, MPH
- Information to come
Other Disclosures
Pamela Kushner, MD, FAAFP (Reviewer): Speaker and Advisor for GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novo Nordisk, Lilly, Haleon, Corcept; Speaker for Phathom, Janssen; Advisor for Bausch/Salix, Bayer, Verdiva, Abbott
All relevant relationships have been mitigated by Pri-Med Institute. All other non-faculty contributors involved in the moderating, planning, development, editing and review of the content have disclosed no relevant financial relationships.